Benefit of mepolizumab for asthma not proven in trials – UPI.com

Benefit of mepolizumab for asthma not proven in trials
UPI.com
Mepolizumab, sold as Nucala, was not compared fairly against other asthma treatments, raising questions as to whether it has benefits over other drugs already used for the condition, the German Institute for Quality and Efficiency in Health Care said
Mepolizumab in severe asthma: Added benefit not provenEurekAlert (press release)

all 3 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *